Literature DB >> 2054914

Principles of measles control.

F T Cutts1, R H Henderson, C J Clements, R T Chen, P A Patriarca.   

Abstract

WHO's Expanded Programme on Immunization has significantly helped to reduce global morbidity and mortality from measles. Recently, some African countries with high vaccine coverage levels have reported measles outbreaks in children above the current target age group for immunization. Outbreaks such as these are to be expected, unless close to 100% of the population are immunized with a vaccine which is 100% effective. Success of an immunization programme requires identification of the distribution and ages of susceptible children and reduction of their concentration throughout the community. Priority should be given to urban and densely populated rural areas. In large urban areas, high coverage of infants must be achieved soon after the age at which they lose their maternal antibodies and become susceptible. This will be facilitated by the introduction of high-dose measles vaccines which can be given at 6 months of age. Where measles incidence is increasing among children aged over 2 years, immunization of older children may be considered during contacts with the health care system, or at primary school entry, if this does not divert resources from immunization of younger children. Health workers should be informed of the predicted changes in measles epidemiology following immunization. The collection, analysis and use of data on measles (vaccine coverage, morbidity and mortality) should be improved at all levels of the health care system in order to monitor the immunization programme's overall impact, identify pockets of low coverage, and allow early detection of and response to measles outbreaks.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054914      PMCID: PMC2393212     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps).

Authors:  R E H SIMPSON
Journal:  Lancet       Date:  1952-09-20       Impact factor: 79.321

2.  Measles--United States, 1989 and first 20 weeks 1990.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-06-01       Impact factor: 17.586

3.  Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life.

Authors:  W R Taylor; R K Mambu; M ma-Disu; J M Weinman
Journal:  Am J Epidemiol       Date:  1988-04       Impact factor: 4.897

4.  Measles control in Yaounde: justification of a one dose, nine month minimum age vaccination policy in tropical Africa.

Authors:  D L Heymann; G K Mayben; K R Murphy; B Guyer; S O Foster
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

5.  Measles, mumps, and rubella vaccine: what coverage to block transmission?

Authors:  D J Nokes; R M Anderson
Journal:  Lancet       Date:  1988-12-10       Impact factor: 79.321

Review 6.  Measles control: so near and yet so far.

Authors:  C D Mitchell; H H Balfour
Journal:  Prog Med Virol       Date:  1985

7.  Measles in England and Wales--I: An analysis of factors underlying seasonal patterns.

Authors:  P E Fine; J A Clarkson
Journal:  Int J Epidemiol       Date:  1982-03       Impact factor: 7.196

8.  Measles in developing countries. Part II. The predicted impact of mass vaccination.

Authors:  A R McLean; R M Anderson
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

Review 9.  Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies.

Authors:  P Aaby
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

Review 10.  Measles immunization research: a review.

Authors:  P Aaby; C J Clements
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

View more
  11 in total

1.  Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.

Authors:  Anna P Toptygina; Alexander L Pukhalsky; Vladimir A Alioshkin
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 2.  Should measles be eradicated?

Authors:  F T Cutts; R Steinglass
Journal:  BMJ       Date:  1998-03-07

Review 3.  Effectiveness of measles vaccination and vitamin A treatment.

Authors:  Christopher R Sudfeld; Ann Marie Navar; Neal A Halsey
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

4.  Improving vaccination coverage in urban areas through a health communication campaign: the 1990 Philippine experience.

Authors:  S Zimicki; R C Hornik; C C Verzosa; J R Hernandez; E de Guzman; M Dayrit; A Fausto; M B Lee; M Abad
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

5.  Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.

Authors:  María Beatríz Isa; Laura Martínez; Miguel Giordano; Carlos Passeggi; María Cristina de Wolff; Silvia Nates
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

6.  Measles virus-specific immunoglobulin G isotype immune response in early and late infections.

Authors:  M B Isa; L Martínez; M Giordano; M Zapata; C Passeggi; M C De Wolff; S Nates
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 7.  Measles control in the United States: problems of the past and challenges for the future.

Authors:  D L Wood; P A Brunell
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

8.  Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination.

Authors:  Petra Klepac; Ottar N Bjørnstad; C Jessica E Metcalf; Bryan T Grenfell
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

9.  Recurring measles epidemic in Vietnam 2005-2009: implication for strengthened control strategies.

Authors:  Jephtha C Nmor; Hoang T Thanh; Kensuke Goto
Journal:  Int J Biol Sci       Date:  2011-01-27       Impact factor: 6.580

Review 10.  Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea.

Authors:  Young June Choe; Youngmee Jee; Myoung-don Oh; Jong-Koo Lee
Journal:  J Korean Med Sci       Date:  2015-11-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.